Amphastar Pharma (AMPH) Tops Q1 EPS by 6c

Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.10, $0.06 better than the analyst estimate of $0.04. Revenue for the quarter came in at $79.8 million versus the consensus estimate of $76.2 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• SanDisk surges as Meta memo confirms multi-year flash storage deal
• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance